Ron Chapman II Keeps Mission to Clear Up Opioid Prescribing Misconceptions, Defend Pain Management Specialists

Various Prescription Pills and Capsules

Being a pain management specialist means being continually conflicted between following regulations for controlled substances and doing what’s best for their pain patients. This is something Ronald W. Chapman II, chair of Chapman Law Group’s White Collar Defense & Government Investigations practice group, has strived to bring attention to, especially as the controversial CDC guidelines for prescribing controlled substances are usurping federal criminal standards and state regulatory standards.

Ron’s mission is getting national attention, the latest instance being his inclusion in a white paper, “Criminalizing Good Medical Care: The Opioid Crisis and How to Practice Safely,” published by PainScored.

In it, Ron’s “Defending Hippocrates: Representing Physicians in the Wake of the Opioid Epidemic” article, which he wrote for the National Association of Criminal Defense Lawyers’ The Champion publication (September-October 2017 edition) is cited:

[Ron] writes about how federal and state prosecutors are more aggressive in investigating and prosecuting DEA registrants for prescribing “outside the course of professional practice.” How is this defined? It is clouded by a U.S. Supreme Court Decision, U.S. v. Moore, which upheld prosecution under the Controlled Substances Act (CSA). In the wake of the decision, federal circuit courts have had trouble understanding “legitimate medical purpose” and “usual course of professional practice.”

[Ron] argues that the “misunderstanding has led to the judicial creation of a ‘criminal standard of care’ for all appropriate prescribing.” It was revisited by the Supreme Court in Gonzales vs. Oregon, which attempted to clarify but ultimately confused the matter. Since then, federal circuit court opinions have held doctors to heightened, and often shifting, standards such as “failure to recognize signs of drug diversion.”

Ron, who focuses exclusively on defending health care providers nationwide who are under investigation by the DEA and federal prosecutors, also is mentioned as saying:

“[A] strong defense requires, “narrowing of the standard, solid expert testimony and a strong presentation of the patient’s medical need for the prescription issued by a physician.

Why Choose Chapman Law Group as Your Federal Healthcare-Based Criminal Defense Team?

Ron has a strong record of defending some of the most high-profile healthcare fraud and unlawful distribution of opioid cases in the country. As a dedicated federal criminal defense attorney, Ron’s defense litigation portfolio included numerous acquittals of providers alleged to have been running pill mills and overprescribing.

With an LL.M. in healthcare among his credentials, he is a sought-after author and speaker on the issue. Ron’s extensive experience and focused practice ensure that his clients get the benefit of a focused and aggressive defense without the big law price tag.

Ron, along with our other healthcare-based criminal law attorneys — Summer McKeivier, Jonathan Meltz, Juan C. Santos, Robert J. Andretz, and Meaghan G. McKeon — has dedicated his career to defending physicians, pharmacists and other healthcare professionals facing federal criminal charges. 

The Healthcare Fraud and Criminal Defense Attorneys at Chapman Law Group Are Your National DEA Defense Experts

At Chapman Law Group, our national DEA attorneys are dedicated to defending prescribers and dispensers against actions such as DEA investigations and audits, DEA raidsDEA registration applications and denials, and DEA registration suspension and revocation issues nationwide. 

We also work with prescribers and dispensers across the U.S. to advise them on state and federal regulations surrounding controlled substances to ensure compliance and prevent investigations and DEA enforcement action.

Our DEA lawyers are experienced in defending DEA registrants both during DEA investigations and in subsequent DEA action if noncompliance with the Controlled Substances Act is found. When an investigation or DEA audit is initiated, we work with clients to respond to DEA complaints, demonstrate compliance, and negotiate agreements between the DEA and client to ensure minimal impact to their DEA Certification and license and reduce penalties.

Among the DEA actions we handle:

We are dedicated to helping national practitioners, pharmacies, distributors and other registrants protect their DEA registration and defend against DEA enforcement action. Our goal is not only to protect the DEA registration of our clients, but to protect their other professional licenses, their career and their reputation from damage caused by DEA investigations and allegations of noncompliance. 

We represent licensed medical professionals, including:

Our offices are in Detroit (where we serve Dearborn, Troy, Ann Arbor and Grand Rapids, and the rest of Michigan); Miami and Sarasota, Florida (for Jacksonville, Tampa, Orlando, West Palm Beach, and all of Florida); Los Angeles/Southern California; and Chicago. Contact us today for more information.

Need an Attorney? Contact us now!

.

  • This field is for validation purposes and should be left unchanged.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Attorneys

Ronald W. Chapman II, LL.M.
Shareholder

Chairperson of White Collar Defense & Government Investigations

Michigan Office
1441 W. Long Lake Road, Suite 310
Troy, MI 48098
Phone: (248) 644-6326

Recent Posts

Related Posts

Blog Categories

Blog Archives

Got A Question?

Call now to schedule a consultation.

Send this to a friend